Bank Julius Baer & Co. Ltd, Zurich Viatris Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$9.02 - $10.29 $4,942 - $5,638	548 New	548 $5,000
Q1 2023 May 11, 2023	BUY	$9.2 - $12.26 $1,140 - $1,520	124 Added 45.26%	398 $4,000
Q4 2022 Jan 24, 2023	BUY	$8.72 - $11.56 $26 - $34	3 Added 1.11%	274 $3,000
Q3 2022 Nov 04, 2022	SELL	$8.48 - $11.13 $8,013 - $10,517	-945 Reduced 77.71%	271 $2,000
Q2 2022 Jul 22, 2022	SELL	$9.95 - $12.27 $1,313 - $1,619	-132 Reduced 9.79%	1,216 $13,000
Q1 2022 May 09, 2022	SELL	$9.81 - $15.4 $6,268 - $9,840	-639 Reduced 32.16%	1,348 $15,000
Q4 2021 Feb 15, 2022	SELL	$12.09 - $14.68 $616 - $748	-51 Reduced 2.5%	1,987 $27,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $20,285 - $23,164	-1,531 Reduced 42.9%	2,038 $28,000
Q2 2021 Jul 23, 2021	SELL	$12.97 - $16.15 $11,530 - $14,357	-889 Reduced 19.94%	3,569 $51,000
Q1 2021 May 10, 2021	SELL	$13.59 - $18.54 $64,878 - $88,509	-4,774 Reduced 51.71%	4,458 $62,000
Q4 2020 Feb 24, 2021	BUY	$14.3 - $18.74 $69,512 - $91,095	4,861 Added 111.21%	9,232 $173,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $62,505 - $81,912	4,371 New	4,371 $173,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.